Efficacy and safety of a combined use of alpha1-blocker doxazosin and phosphodiesterase-5 inhibitor udenafil in patients with benign prostatic hyperplasia
The paper presents the results of examination and treatment in 32 men aged 45 to 73 years with lower urinary tract symptoms caused by benign prostatic hyperplasia. The examination revealed that 53.1 % of patients reported reduced erectile function. All patients received doxazosin (Artezin ®) from 2...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-11-01
|
| Series: | Andrologiâ i Genitalʹnaâ Hirurgiâ |
| Subjects: | |
| Online Access: | https://agx.abvpress.ru/jour/article/view/48 |